Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) went public through a merger with Soaring Eagle Acquisition Corp., a blank-check company sponsored by Eagle Equity Partners that completed its IPO in January 2021. The 8-K filing dated May 11, 2021 announced the definitive business combination agreement, a significant transaction in the synthetic biology and life sciences sector. Ginkgo, which operates a platform for engineering microorganisms across commercial, industrial, and pharmaceutical applications, began trading under the ticker DNA on the New York Stock Exchange after the deal closed in September 2021. Sign up on SpacDesk for complete filing data, deal timelines, and analytics on this and every SPAC transaction.